|
|
|||||||||||||||
| |||||||||||||||
 UBBFriend: Email This Page to Someone! |
 HUM-MOLGEN
 Biotechnical requests and sources
 Viwit increases Methyl Oxazaborolidine (MeCBS) production capacity
|
| next newest topic | next oldest topic |
| Author | Topic: Viwit increases Methyl Oxazaborolidine (MeCBS) production capacity |
|
viwit Member |
posted 12-16-2008 01:43 AM
   
Shanghai, China, Dec 15 2008 Viwit Pharmaceutical Co., Ltd. (Viwit) announced the increase in production capacity of (R)-Methyl Oxazaborolidine, or (R)-MeCBS, or (R)-2-Methyl-CBS-oxazaborolidine in Toluene (CAS # 112022-83-0) and (S)-Methyl Oxazaborolidine, or (S)-MeCBS, or (S)-2-Methyl-CBS-oxazaborolidine in Toluene (CAS # 112022-81 -8). Viwit current production capacity reaches 3,500 kgs per year, and further capacity increase is also under preparation. MeCBS reagents are used as a catalyst for catalytic asymmetric reduction of ketones. This technology is an excellent tool for the synthesis of chiral alcohol in high enantiomeric excess, and is used in the synthesis of more than a dozen of high potency APIs such as Ezetimibe, Aprepitant, Fosaprepitant and Luliconazole.
[This message has been edited by viwit (edited 12-17-2008).] IP: 116.225.247.249 |
All times are ET (US) | next newest topic | next oldest topic |
  |
|
Contact Us | HUM-MOLGEN
Copyright by HUM-MOLGEN 1995-2017
Powered by: Ultimate Bulletin Board, Version 5.44a
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.